Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1979 1
1986 5
1987 4
1988 2
1989 1
1990 2
1991 3
1994 1
1995 1
1996 1
1997 2
1998 1
1999 3
2000 4
2001 2
2002 2
2003 3
2004 9
2005 2
2006 6
2007 5
2008 1
2009 7
2010 6
2011 8
2012 15
2013 9
2014 15
2015 15
2016 7
2017 11
2018 13
2019 11
2020 19
2021 13
2022 11
2023 16
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Ferulic acid: pharmacological and toxicological aspects.
Mancuso C, Santangelo R. Mancuso C, et al. Among authors: santangelo r. Food Chem Toxicol. 2014 Mar;65:185-95. doi: 10.1016/j.fct.2013.12.024. Epub 2013 Dec 25. Food Chem Toxicol. 2014. PMID: 24373826 Review.
Resting-state electroencephalographic biomarkers of Alzheimer's disease.
Cecchetti G, Agosta F, Basaia S, Cividini C, Cursi M, Santangelo R, Caso F, Minicucci F, Magnani G, Filippi M. Cecchetti G, et al. Among authors: santangelo r. Neuroimage Clin. 2021;31:102711. doi: 10.1016/j.nicl.2021.102711. Epub 2021 May 29. Neuroimage Clin. 2021. PMID: 34098525 Free PMC article.
Novel NMDA receptor modulators: an update.
Santangelo RM, Acker TM, Zimmerman SS, Katzman BM, Strong KL, Traynelis SF, Liotta DC. Santangelo RM, et al. Expert Opin Ther Pat. 2012 Nov;22(11):1337-52. doi: 10.1517/13543776.2012.728587. Epub 2012 Sep 26. Expert Opin Ther Pat. 2012. PMID: 23009122 Free PMC article. Review.
Neuro-Retina Might Reflect Alzheimer's Disease Stage.
Santangelo R, Huang SC, Bernasconi MP, Falautano M, Comi G, Magnani G, Leocani L. Santangelo R, et al. J Alzheimers Dis. 2020;77(4):1455-1468. doi: 10.3233/JAD-200043. J Alzheimers Dis. 2020. PMID: 32925026
Is smallpox vaccination protective against human monkeypox?
Moschese D, Farinacci D, Pozza G, Ciccullo A, Cossu MV, Giacomelli A, Borgonovo F, Mileto D, Santangelo R, Tamburrini E, Rizzardini G, Antinori S, Giambenedetto SD. Moschese D, et al. Among authors: santangelo r. J Med Virol. 2023 Jan;95(1):e28077. doi: 10.1002/jmv.28077. Epub 2022 Sep 2. J Med Virol. 2023. PMID: 35993271 No abstract available.
219 results